Series: Ask the IRB & IBC Experts
WCG’s IRB & IBC Review professionals get questions about clinical research all the time: from researchers, clinical team members at biopharma companies, and from members of institutional IRBs. We know that for many of the questions, the person asking is not the only one struggling with that issue. We’ve built this forum as an immediate and less formal way to share information across the clinical research community.
Series: Ask the IRB & IBC Experts
Should Consent Form updates be aligned with Investigator Brochure updates, or wait for next Protocol amendment?
Blog Posts
Ethics in Clinical Research
What are the requirements for parental permission (consent) in studies involving children?
Blog Posts
Regulatory Compliance
How do I handle a deviation in the use of blood specimens collected outside the timeframe?
Blog Posts
Series: Ask the IRB & IBC Experts
Is it possible to make a PI’s name or institution confidential on a consent form?
Blog Posts
Series: Ask the IRB & IBC Experts
What are the Blood Draw Guidelines for Phase 1 Clinical Trials?
Blog Posts
Regulatory Compliance
Guidance on genomic research with deceased patients
Blog Posts
Ethics in Clinical Research
If a Subject’s Care Is Divided Equally Between Two Caregivers, Who Should Sign Caregiver Consent?
Blog Posts
Regulatory Compliance
Can we charge a subject for a diagnostic test not done as part of the IRB approved protocol?
Blog Posts
Regulatory Compliance
How should a site document a missing signature on a HIPAA authorization form?
Blog Posts
Clinical Trial Safety